Mankind Pharma acquires Bharat Serums and Vaccines for INR 13,630 Cr | Entrepreneur
Excerpt from Entrepreneur: “Mankind Pharma announced that it has entered into a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for an enterprise value of INR 13,630 crore.” Read more.
Migraine relief recall: medicine sold by Amazon, ‘risk of misuse’ | Fast Company
Excerpt from Fast Company: “A batch of over-the-counter migraine relief medication that was shipped by Amazon is being recalled nationwide because it was missing the required manufacturer labels.” Read more.
Is Vertex Pharmaceuticals’ monopoly in danger? | The Motley Fool
Excerpt from The Motley Fool: “Over the past decade, Vertex Pharmaceuticals has delivered above-average returns. The secret behind the biotech’s success isn’t much of a secret. The drugmaker developed and marketed medicines — the only ones in the world — that target the underlying causes of a rare disease called cystic fibrosis (CF). So far, Vertex’s monopoly has remained intact despite many of its peers trying to break into this space. But could that change soon? Sionna Therapeutics, a privately held biotech, certainly hopes so.” Read more.
Sorry, the comment form is closed at this time.